关键词：睾丸癌；疾病；生殖细胞
摘 要：Testicular cancer is a disease that affects the testicles, and it basically arises from the germ cells where sperm is produced. Though the exact reason of testicular cancer is unknown, some of the factors that increase the risk of disease include abnormal testicle development, family history of testicular cancer, undescended testicle, exposure to certain chemicals and HIV infection, and Klinefelter syndrome. Testicular cancer is the most common form of cancer in men between the ages of 15 and 35. Moreover, white Americans are more likely to develop this type of cancer. There are two main types of testicular cancer: seminomas and non-seminomas. There are three types of treatment options for this disease and it depends on the type of testicular tumor and stage of the tumor. Testicular cancer may also spread to other parts of the body such as abdomen, lungs, the area near the kidneys, and spine.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Testicular Cancer by Type

07.1.1 Seminoma

07.1.2 Non-seminoma

08. Testicular Cancer Disease by Stages

08.1.1 Stage 0

08.1.2 Stage I

08.1.3 Stage II

08.1.4 Stage III

09. Treatment Options

09.1 Surgery

09.2 Radiation Therapy

09.3 Chemotherapy

10. Clinical Trial Snapshot

11. Geographical Segmentation

11.1 Global Testicular Cancer Drugs Market by

Geographical Segmentation

12. Buying Criteria

13. Rate of Incidence and Prevalence

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape

20.1 Competitive Scenario

20.1.1 Key News

20.1.2 Acquisitions

20.2 Other Prominent Vendors

21. Key Vendor Analysis

21.1 Bristol-Myers Squibb Co.

21.1.1 Business Overview

21.1.2 Key Information

21.1.3 SWOT Analysis

21.2 Hospira Inc.

21.2.1 Business Overview

21.2.2 Business Segmentation

21.2.3 Key Information

21.2.4 SWOT Analysis

21.3 Teva Pharmaceutical Industries Ltd.

21.3.1 Business Overview

21.3.2 Business Segmentation

21.3.3 Key Information

21.3.4 SWOT Analysis

21.4 ZIOPHARM Oncology Inc.

21.4.1 Business Overview

21.4.2 Key Information

21.4.3 SWOT Analysis

22. Other Reports in this Series